Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy
Nature Reviews Nephrology 11, 68 (2015).
doi:10.1038/nrneph.2014.238
Authors: Hans-Henrik Parving & Peter Rossing
In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Hans-Henrik ParvingPeter Rossing Tags: Year in Review Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Study | Urology & Nephrology